The presence of SP1 together with IL2 signaling regulators, IGFBP2, IMPDH2 and HTT in separate subnetworks that excludes RAC signaling component might indicate the presence of at least two non-redundant mechanisms in P-inter breast cancers that may determine patient outcomes. This evidence concerns the gene IMPDH2 and breast carcinoma.